EARLY ACTION ON DIABETES: THE POWER OF PREVENTION, EARLY DETECTION AND INTEGRATIVE MANAGEMENT By Livy-Elcon Emereonye
EARLY ACTION ON DIABETES: THE POWER OF PREVENTION, EARLY DETECTION AND INTEGRATIVE MANAGEMENT
A World Diabetes Day 2026 Commemorative Scientific and Public Health Article
By Livy-Elcon Emereonye
Introduction: Diabetes – A Growing Public Health Challenge
Diabetes mellitus remains one of the most significant public health challenges of the 21st century. Its growing prevalence, long-term complications, economic implications and increasing burden on healthcare systems make it a disease that demands urgent, sustained and coordinated action.
Yet, one of the greatest problems associated with diabetes is not merely its prevalence but the delay in its recognition, diagnosis and appropriate management.
Millions of people live with diabetes without knowing it. Others become aware of their condition only after developing complications involving the eyes, kidneys, nerves, heart and blood vessels.
This is particularly concerning because many of these complications can be prevented, delayed or significantly reduced through timely intervention.
World Diabetes Day, commemorated annually on 14 November, provides an important opportunity to renew public awareness, strengthen preventive healthcare and mobilise individuals, families, healthcare professionals, policymakers and other stakeholders towards more effective diabetes control.
The 2026 focus, Early Action on Diabetes, reinforces an essential public health message: the best time to act against diabetes is before complications develop, and ideally before the disease itself becomes established.
Understanding Diabetes Mellitus
Diabetes mellitus is a group of metabolic disorders characterised by persistently elevated blood glucose levels resulting from inadequate insulin production, impaired insulin action, or a combination of both.
Insulin, a hormone produced by the beta cells of the pancreas, plays a central role in regulating blood glucose by facilitating glucose uptake and utilisation by body tissues.
When insulin production is insufficient or the body's cells become resistant to its action, glucose accumulates in the bloodstream, resulting in hyperglycaemia.
The major forms of diabetes include:
1. Type 1 Diabetes
This results from autoimmune destruction of the insulin-producing beta cells of the pancreas, leading to absolute insulin deficiency. People living with type 1 diabetes require lifelong insulin treatment.
2. Type 2 Diabetes
This is the most common form of diabetes and is characterised by insulin resistance, progressive impairment of insulin secretion, or both.
It is associated with several modifiable and non-modifiable risk factors, including excess body weight, physical inactivity, unhealthy dietary patterns, family history, increasing age and certain metabolic conditions.
Importantly, type 2 diabetes is increasingly being diagnosed in younger populations.
3. Gestational Diabetes Mellitus
This develops during pregnancy and is characterised by elevated blood glucose levels that were not clearly present before pregnancy.
It increases the risk of complications during pregnancy and delivery and also raises the future risk of type 2 diabetes in the mother.
Other specific forms of diabetes may result from genetic conditions, pancreatic diseases, endocrine disorders and certain medications.
Understanding these differences is important because diabetes is not a single disease with one uniform cause or treatment approach.
The Global Diabetes Burden: Why Early Action Matters
According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20–79 years were living with diabetes worldwide in 2024. The figure is projected to rise to approximately 853 million by 2050 if effective preventive and management interventions are not strengthened.
A particularly worrying aspect is that a substantial proportion of affected individuals remain undiagnosed.
Undiagnosed diabetes represents a significant public health concern because the disease may continue to damage vital organs long before the individual becomes aware of its presence.
For Nigeria and other African countries, the challenge is compounded by limited access to routine screening, inadequate awareness, late presentation, the cost of healthcare, inconsistent access to medicines and insufficient continuity of care.
Consequently, diabetes should no longer be regarded merely as an individual medical condition. It is a development, economic and public health concern that requires collective responsibility.
Early Action: What Does It Really Mean?
Early action on diabetes goes beyond checking blood glucose when someone becomes ill.
It involves a proactive approach that begins with risk identification, progresses through prevention and early diagnosis, and continues with appropriate treatment, monitoring and complication prevention.
There are five important dimensions of early action.
1. Early Risk Identification and Assessment
The first step is identifying individuals who are at increased risk of developing diabetes.
Risk assessment should consider:
- Family history of diabetes.
- Overweight and obesity, particularly abdominal obesity.
- Physical inactivity and sedentary lifestyles.
- Unhealthy dietary habits.
- Previous gestational diabetes.
- Hypertension and abnormal blood lipid levels.
- Previous identification of prediabetes.
- Increasing age and other relevant clinical risk factors.
Individuals with these risk factors should be encouraged to undergo appropriate medical assessment and blood glucose testing.
However, the absence of recognised risk factors does not completely eliminate the possibility of developing diabetes.
2. Early Detection Through Routine Screening
One of the most effective ways to reduce the burden of undiagnosed diabetes is to strengthen routine screening.
Diabetes can remain asymptomatic for several years. Therefore, waiting for symptoms before checking blood glucose is an inadequate public health strategy.
Common diagnostic tests include: Fasting Plasma Glucose (FPG): A fasting plasma glucose level of 7.0 mmol/L (126 mg/dL) or higher is within the diabetic range.
Glycated Haemoglobin (HbA1c): An HbA1c level of 6.5% or higher indicates diabetes when measured using an appropriately standardised laboratory method.
Oral Glucose Tolerance Test (OGTT): A two-hour plasma glucose level of 11.1 mmol/L (200 mg/dL) or higher following a 75 g oral glucose load is diagnostic.
Random Plasma Glucose: A result of 11.1 mmol/L (200 mg/dL) or higher, in the presence of classic symptoms of hyperglycaemia or a hyperglycaemic crisis, can establish the diagnosis.
In individuals without unequivocal hyperglycaemia, an abnormal diagnostic result generally requires confirmation.
It is important to distinguish screening from diagnosis. An abnormal screening result should be appropriately evaluated by a qualified healthcare professional.
Early detection creates an opportunity for timely treatment and reduces the likelihood of presenting with advanced complications.
3. Early Lifestyle Intervention: Prevention Before Complications
Lifestyle modification is one of the most important components of diabetes prevention and management.
For people at increased risk of type 2 diabetes, evidence-based lifestyle interventions can substantially reduce the likelihood of progression to the disease.
Healthy Nutrition: A balanced dietary pattern should include vegetables, fruits in appropriate portions, whole grains, legumes, nuts and suitable sources of protein. Consumption of sugar-sweetened beverages, excessive refined carbohydrates, highly processed foods and energy-dense meals should be reduced.
In the Nigerian context, healthy eating does not necessarily mean abandoning traditional foods. It means making better choices in food composition, preparation methods, portion sizes and frequency of consumption.
Regular Physical Activity: Adults should generally aim for at least 150 minutes of moderate-intensity aerobic physical activity weekly, alongside muscle-strengthening activities on two or more days.
Weight Management: For individuals with overweight or obesity who are at increased risk of type 2 diabetes, achieving and maintaining a clinically appropriate reduction in body weight can significantly reduce diabetes risk.
Adequate Sleep and Stress Management: Poor sleep patterns, chronic stress and unhealthy coping behaviours can adversely affect metabolic health.
Avoidance of Tobacco and Harmful Alcohol Consumption: Tobacco use increases cardiovascular risk, while excessive alcohol consumption can contribute to several metabolic and other health problems.
These interventions are not merely recommendations for people already diagnosed with diabetes. They are preventive measures for the entire population.
4. Early Treatment and Effective Disease Management
Once diabetes is diagnosed, appropriate treatment should commence without unnecessary delay.
The treatment plan should be individualised according to the type of diabetes, age, cardiovascular and kidney health, other medical conditions, patient preferences and available resources.
Management may involve:
- Appropriate dietary modification.
- Regular physical activity.
- Weight management.
- Oral glucose-lowering medications.
- Injectable medications, including insulin where indicated.
- Blood glucose monitoring.
- Regular assessment of treatment response and potential adverse effects.
For people with type 1 diabetes, insulin is essential for survival.
For people with type 2 diabetes, medication selection should consider not only blood glucose reduction but also cardiovascular, kidney and weight-related benefits where appropriate.
It is equally important to recognise that diabetes management is not limited to achieving acceptable blood glucose levels.
A comprehensive approach must also address blood pressure, blood lipid levels, kidney function, eye health, foot health and other cardiovascular risk factors.
5. Early Identification and Prevention of Diabetes Complications
One of the most important reasons for early intervention is the prevention or delay of diabetes-related complications.
Persistently elevated blood glucose can damage blood vessels and nerves, affecting multiple organs and systems.
The major complications include:
- Diabetic Retinopathy: Damage to the small blood vessels of the retina, potentially resulting in visual impairment and blindness.
- Diabetic Nephropathy: Progressive kidney damage that can eventually lead to chronic kidney disease and kidney failure.
- Diabetic Neuropathy: Nerve damage that may cause pain, tingling, numbness and loss of protective sensation.
- Cardiovascular Diseases: Increased risk of heart attack, stroke and peripheral arterial disease.
- Diabetic Foot Complications: Foot ulcers, infections and tissue damage that may ultimately result in amputation.
Early identification through appropriate retinal examinations, kidney function assessment, urine albumin testing, foot examinations and cardiovascular risk assessment is essential.
6. Integrative Management Approach to Diabetes: Combining the Best of Evidence-Based Healthcare
Diabetes is a complex metabolic disorder. Its effective management therefore requires more than an isolated intervention or dependence on a single therapeutic approach.
An integrative management approach recognises the potential value of combining conventional medical treatment, evidence-based nutritional and lifestyle interventions, patient education and appropriately evaluated complementary healthcare practices.
The central principle is not to replace established medical treatment with alternative remedies but to bring together safe, scientifically defensible interventions that address different aspects of metabolic health.
An effective integrative approach should incorporate the following components:
A. Conventional Medical Management
Conventional medical care remains the foundation of diabetes treatment.
Depending on the type and severity of diabetes, this may include insulin, oral glucose-lowering medicines and other evidence-based pharmacological interventions.
Regular clinical evaluation is necessary to determine treatment effectiveness, adjust medication and identify complications.
B. Nutritional and Lifestyle Medicine
Nutrition, physical activity, weight management, adequate sleep and stress reduction are important components of integrative diabetes care.
These interventions can improve insulin sensitivity, support metabolic regulation and reduce cardiovascular risk.
They should be incorporated into individualised management plans rather than treated as optional additions.
C. Pharmacognosy and Evidence-Based Herbal Medicine
Medicinal plants contain diverse phytochemicals, including flavonoids, alkaloids, terpenoids, phenolic compounds and other bioactive constituents.
Some of these compounds have demonstrated biological activities relevant to glucose metabolism in laboratory and preclinical investigations. Research has explored possible effects on insulin sensitivity, glucose absorption, oxidative stress, inflammation and pancreatic beta-cell function.
However, biological activity in laboratory experiments does not automatically establish clinical effectiveness in humans.
Herbal preparations therefore require appropriate identification, authentication, standardisation, quality control, safety assessment, dose determination and well-designed clinical investigations before their therapeutic claims can be established.
This is particularly important in diabetes because some herbal preparations may interact with conventional glucose-lowering medicines, potentially increasing the risk of hypoglycaemia or producing other adverse effects.
Consequently, herbal medicine should be approached through scientific evaluation, responsible product development and appropriate clinical supervision.
D. Sudiac® Capsules: A Letonia Healthcare Contribution to Healthy Blood Sugar Management
Sudiac® Capsules, a herbal product developed and marketed by Letonia Int'l Ltd under its Letonia Healthcare brand, are intended for the management of healthy blood sugar.
Sudiac® provides an opportunity to highlight the place of properly developed herbal products within broader conversations about integrative healthcare and metabolic wellness.
The development and responsible use of herbal products in this area should be guided by sound pharmaceutical principles, including:
- Proper identification and authentication of medicinal plant materials.
- Appropriate extraction and formulation procedures.
- Standardisation and quality assurance.
- Assessment of microbial contamination, heavy metals and other potential contaminants.
- Evaluation of safety, dosage and potential herb–drug interactions.
- Scientific substantiation of specific therapeutic claims through appropriate research.
For people interested in complementary herbal healthcare, the important consideration is not simply whether a product is labelled herbal, but whether its quality, safety and claimed benefits are adequately established.
Accordingly, Sudiac® should be considered only within the appropriate product information, applicable regulatory authorisation and professional healthcare guidance.
People already receiving diabetes treatment should consult their healthcare professionals before introducing any herbal product, as concurrent use may require additional monitoring and clinical assessment.
E. Continuous Monitoring and Individualised Care
An effective integrative approach must be measurable.
Blood glucose, HbA1c, blood pressure, lipid profile, kidney function, body weight and other clinically relevant indicators should be monitored at appropriate intervals.
Treatment should be adjusted according to the individual's response, clinical needs and safety considerations.
The ultimate objective is not merely to reduce blood glucose but to improve overall health, preserve organ function, prevent complications and enhance quality of life.
The Scientific Position: Integrative healthcare should complement, not compromise, evidence-based medical care. The inclusion of herbal medicine must be accompanied by scientific validation, pharmaceutical quality assurance, regulatory compliance and responsible clinical practice.
Diabetes and the Nigerian Public Health Environment
Nigeria faces a growing non-communicable disease burden, with diabetes contributing significantly to morbidity, premature mortality and household healthcare expenditure.
Several factors complicate the country's diabetes response.
Inadequate awareness: Many individuals do not appreciate the relationship between lifestyle, metabolic health and diabetes.
Late diagnosis: Some people discover they have diabetes only after developing complications or presenting to hospitals with severe symptoms.
Affordability and accessibility: The cost of diagnostic investigations, medicines, glucose-monitoring supplies and specialist consultations can make consistent management diconsumptio
Misconceptions and misinformation: Some individuals believe diabetes is exclusively caused by excessive sugar consumption, while others assume that the absence of symptoms means they do not have the disease.
There are also misconceptions that diabetes can be permanently cured through unverified herbal preparations, dietary products or alternative remedies.
These beliefs can encourage treatment abandonment and delay appropriate medical care.
The Nigerian response must prioritise accessible screening, reliable diagnostic services, affordable essential medicines, public health education and continuity of care.
Recognising Diabetes Warning Signs
Symptoms that should never be ignored include:
- Excessive thirst.
- Frequent urination.
- Increased hunger.
- Unexplained weight loss.
- Persistent tiredness.
- Blurred vision.
- Slow-healing wounds.
- Recurrent infections.
- Tingling or numbness in the hands and feet.
When accompanied by abdominal pain, vomiting, deep or rapid breathing, dehydration or altered consciousness, diabetic ketoacidosis should be suspected. This is a medical emergency requiring immediate hospital attention.
Who Has a Responsibility to Act?
Early action on diabetes cannot be left to physicians, endocrinologists or people already diagnosed with the disease.
It requires a whole-of-society approach.
Individuals should understand their risk factors, adopt healthy lifestyles, participate in appropriate screening and seek medical attention when necessary.
Families should encourage healthy eating, physical activity, regular health checks and treatment adherence.
Healthcare Professionals should strengthen preventive counselling, risk assessment, early diagnosis, appropriate treatment and patient education.
Pharmacists should use their accessibility to promote diabetes awareness, identify people who may need screening, counsel patients on medicines, encourage adherence and support appropriate referrals.
Herbal Medicine Researchers and Manufacturers should prioritise scientific research, product standardisation, safety evaluation, quality assurance and regulatory compliance.
Government and Policymakers should strengthen primary healthcare services, improve access to essential medicines and diagnostic facilities, support public health campaigns and integrate diabetes prevention into national health strategies.
Schools, Workplaces and the Media should promote healthy environments, physical activity, access to screening and scientifically accurate public health information.
Turning Awareness into Action: Practical Steps Everyone Can Take
World Diabetes Day should not end with speeches, publications, lectures and social media campaigns.
It should translate into measurable improvements in health behaviour and healthcare access.
Every individual can begin with the following actions:
1. Know your diabetes risk factors.
2. Check your blood glucose when clinically indicated.
3. Maintain a healthy body weight.
4. Adopt a balanced dietary pattern.
5. Engage in regular physical activity.
6. Avoid tobacco and harmful alcohol consumption.
7. Know your blood pressure and cholesterol levels.
8. Seek medical assessment when symptoms develop.
9. If diagnosed, adhere to your prescribed treatment.
10. Encourage family members and colleagues to take preventive health checks seriously.
For healthcare organisations, community groups and policymakers, the priority should be to expand access to screening, strengthen referral systems, improve treatment continuity and measure outcomes.
In conclusion, it should be noted that early action is an investment in life.
Diabetes is a serious metabolic disorder, but its consequences are not inevitable.
Type 2 diabetes can often be prevented or delayed among people at increased risk. Diabetes can also be detected early, managed effectively and its complications substantially reduced through evidence-based interventions.
An integrative approach offers additional opportunities to strengthen diabetes care by bringing together conventional medicine, nutrition, lifestyle interventions, pharmaceutical science and scientifically evaluated complementary therapies.
However, integration must never become an excuse for replacing proven treatment with unverified claims.
As we commemorate World Diabetes Day on 14 November 2026, let us move beyond awareness to meaningful action.
Let individuals take responsibility for their health, let families become advocates of preventive healthcare, let healthcare professionals strengthen early intervention, let researchers advance scientific discovery, and let governments make diabetes prevention and treatment more accessible and affordable.
Do not wait until diabetes announces itself through complications. Know your risks, check your numbers, act early and protect your future.
Because when it comes to diabetes, early action is not just good healthcare; it is a life-saving investment.
PS: Dr. Emereonye could be reached on: +234 803 392 2445
References
1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 11th Edition. Brussels, Belgium: International Diabetes Federation; 2025. https://diabetesatlas.org/
2. World Health Organization. Diabetes. WHO Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes
3. World Health Organization. Global Report on Diabetes. Geneva: WHO; 2016. https://www.who.int/publications/i/item/9789241565257
4. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1).
5. American Diabetes Association Professional Practice Committee. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1).
6. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346:393–403. doi:10.1056/NEJMoa012512.
7. Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2022;45(11):2753–2786. doi:10.2337/dci22-0034.
8. World Health Organization. HEARTS D: Diagnosis and Management of Type 2 Diabetes. Geneva: WHO; 2020. https://www.who.int/publications/i/item/9789240009226
9. World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. Geneva: WHO; 2019. https://www.who.int/publications/i/item/978924151536








Abstract
Medicinal plants have contributed substantially to human healthcare for centuries and continue to provide important therapeutic resources for both traditional and modern medicine. Despite their potential, the transition from medicinal plant material to reliable herbal medicinal products remains challenging. Variability in botanical identity, cultivation, harvesting, processing, extraction, phytochemical composition, formulation, storage and administration can significantly influence the quality, safety, reproducibility and therapeutic performance of herbal preparations.
This chapter examines the emerging concept of Herbaceutics, defined as the science and art of herbal dosage-form design and formulation, as a translational discipline within modern herbal medicine development. Although Herbaceutics draws upon pharmacognosy, phytochemistry, pharmacology, toxicology and conventional pharmaceutics, its distinctive contribution is the formulation-centred transformation of complex botanical preparations into stable, reproducible, appropriately dosed and patient-acceptable medicinal products. Particular attention is given to standardization, quality assurance, dosage-form development, drug-delivery considerations, Quality by Design (QbD), advanced analytical technologies, safety, herb–drug interactions, clinical evidence, regulatory science and sustainable development.
The chapter further considers opportunities for medicinal-plant pharmaceutical development across different regions of the world and proposes an integrated plant-to-product framework encompassing botanical identification, authentication, preparation development, pharmacological and safety evaluation, Herbaceutic formulation, manufacturing, clinical and regulatory translation, commercialization and pharmacovigilance. The central proposition is that the medicinal plant should be regarded as the starting material rather than the finished medicine. Herbaceutics can provide an important scientific and technological bridge between botanical therapeutic potential and reproducible medicinal products suitable for contemporary healthcare.
Keywords: Medicinal plants; herbal medicine; Herbaceutics; herbal formulation; dosage forms; phytotherapy; standardization; quality control; phytopharmaceuticals; traditional medicine; drug delivery; evidence-based medicine.
1. Introduction
Medicinal plants constitute one of humanity's oldest and most enduring sources of healthcare. Across cultures and civilizations, plants have been used to prevent, alleviate and manage disease. Contemporary pharmaceutical science has also demonstrated the importance of natural products as sources of biologically active compounds and therapeutic leads.
The continued relevance of medicinal plants is reflected in the widespread use of traditional and complementary medicine globally. However, the existence of a long history of traditional use does not automatically guarantee that every botanical preparation is consistent, safe, effective or suitable for modern pharmaceutical use. The major challenge is therefore no longer simply the identification of medicinal plants but the scientific translation of botanical resources into reliable medicinal products.
Unlike many conventional medicines based on relatively well-defined active pharmaceutical ingredients, herbal medicines may contain complex mixtures of primary and secondary metabolites. Their composition can be influenced by genetic factors, geographical origin, soil, climate, cultivation practices, maturity, harvesting conditions, post-harvest processing, extraction procedures, storage and formulation.
Consequently, two preparations described as being derived from the same plant may not necessarily possess identical chemical or biological characteristics. Differences in preparation may influence stability, dose, bioavailability, pharmacological activity and safety.
These challenges have stimulated increasing interest in authentication, chemical characterization, standardization, advanced analytical technologies, pharmacological evaluation and modern dosage-form development. Nevertheless, an important conceptual gap remains between the medicinal plant or botanical extract and the finished medicinal product.
This chapter proposes Herbaceutics as an emerging discipline addressing this gap. Herbaceutics focuses particularly on the design and formulation of herbal dosage forms while recognizing the distinctive physicochemical, biological and manufacturing characteristics of botanical materials.
The objective is not to replace established disciplines such as pharmacognosy, phytochemistry or pharmaceutics, but to establish a coherent formulation-centred interface through which knowledge from these disciplines can be translated into reproducible herbal medicines.
2. The Medicinal Plant–Medicine Continuum
The development of a medicinal product from a plant is a continuum rather than a single event. It begins with the identification of a potentially useful botanical resource and extends through authentication, cultivation or collection, preparation, extraction, characterization, pharmacological and safety assessment, formulation, manufacturing, clinical evaluation, regulatory approval and post-market surveillance.
Traditional knowledge may provide the initial indication that a plant possesses therapeutic potential. Ethnobotanical information can therefore be valuable in identifying species, plant parts, preparation methods and therapeutic applications worthy of scientific investigation.
However, traditional knowledge and pharmaceutical evidence answer different questions. Traditional use may establish historical or empirical relevance, whereas modern development requires additional information concerning identity, composition, dose, mechanism, safety, reproducibility, pharmacokinetics and clinical performance.
The medicinal plant should consequently be viewed as a starting material in a development process, rather than automatically regarded as a finished medicine.
At each stage, new sources of variability may be introduced. For example, genetic variation can influence phytochemical composition; environmental conditions can modify metabolite production; harvesting and drying can affect chemical stability; extraction can alter the concentration and relative proportions of constituents; and formulation can determine stability, dissolution, release and patient acceptability.
The final product therefore reflects the cumulative effects of the entire development pathway.
A scientifically responsible herbal medicine programme must consequently connect botanical science with pharmaceutical development rather than treating them as separate activities.
3. Herbaceutics: Its Distinct Contribution to Herbal Medicine
Herbaceutics may be conceptualized as the science and art of herbal dosage-form design and formulation.
It draws upon pharmacognosy, phytochemistry, pharmaceutics, pharmacology, toxicology, analytical science and related disciplines, but its principal focus is the transformation of medicinal plant preparations into appropriate, reproducible and stable dosage forms for human use.
Its distinctiveness arises from the nature of botanical medicines. Conventional pharmaceutics frequently begins with a relatively well-characterized active pharmaceutical ingredient. Herbal preparations, in contrast, may contain numerous constituents whose concentrations and interactions vary according to species, chemotype, cultivation, harvesting, processing, extraction and storage.
These characteristics create formulation and product-development challenges that cannot always be addressed simply by applying conventional pharmaceutical techniques.
Herbaceutics therefore addresses five closely related problems:
3.1 Botanical-to-product translation
Herbaceutics transforms a complex botanical preparation into a pharmaceutical dosage form such as a capsule, tablet, liquid preparation, cream, gel, powder or other appropriate delivery system.
3.2 Linking botanical characteristics to dosage-form performance
The physical and chemical characteristics of an extract or plant-derived preparation influence properties such as flow, compressibility, solubility, dissolution, stability, release and manufacturability. Herbaceutic development seeks to understand and manage these relationships.
3.3 Designing for reproducibility
Because botanical materials naturally vary, formulation and manufacturing processes must be designed to minimize unacceptable variability and maintain defined quality attributes.
3.4 Optimizing herbal delivery
The selection of dosage form, excipients, processing conditions, route of administration and, where appropriate, advanced delivery technologies can influence the performance and acceptability of herbal medicines.
3.5 Creating the plant-to-patient bridge
Herbaceutics connects the characterized botanical preparation with a practical dosage form that can be administered consistently to patients.
Thus, Herbaceutics is not synonymous with pharmacognosy, phytochemistry, quality control or conventional pharmaceutics. Neither does it encompass the entire medicinal-plant development pathway. Rather, it provides the formulation and dosage-form bridge within that pathway.
Its central question can be expressed as:
"How can a biologically active botanical preparation be transformed into a reproducible, stable, appropriately dosed and quality-assured medicinal product?"
This formulation-centred perspective provides an important conceptual foundation for integrating botanical science with modern pharmaceutical development.
4. Standardization, Quality and Reproducibility
Quality is fundamental to the development and responsible use of herbal medicines. In botanical products, quality encompasses identity, purity, composition, consistency, stability and the absence or control of undesirable contaminants.
Standardization should not be understood simply as making every plant preparation chemically identical. Rather, it involves establishing appropriate specifications and controls that ensure a product possesses defined and reproducible quality characteristics.
Authentication is the first requirement. Correct botanical identification protects against substitution, adulteration and accidental use of inappropriate species. Macroscopic and microscopic examination may be supplemented by chromatographic, spectroscopic, molecular or DNA-based methods.
Raw materials must also be evaluated for contaminants and other undesirable substances. Depending on the material and production system, relevant concerns may include microorganisms, heavy metals, pesticides, aflatoxins, undeclared pharmaceuticals and other contaminants.
Chemical characterization provides another important layer of quality assurance. Chromatographic fingerprints, marker compounds and quantitative analytical methods can help characterize botanical preparations. Increasingly, metabolomics and other comprehensive analytical approaches offer opportunities to assess complex chemical profiles.
However, chemical consistency alone may not fully represent biological consistency. Where appropriate, analytical characterization should therefore be complemented by pharmacological or biological assays relevant to the intended therapeutic activity.
Reproducibility should be addressed across the complete production chain—from botanical source and processing through extraction, formulation, packaging and storage.
The objective is to establish a controlled relationship between raw material quality, process parameters, product characteristics and intended performance.
5. Herbaceutic Formulation and Drug Delivery
Formulation is the stage at which the characteristics of a botanical preparation are deliberately converted into a usable dosage form.
The selection of a dosage form should reflect the nature of the preparation, intended route of administration, therapeutic objective, dose requirements, stability, patient population, manufacturing capacity and regulatory expectations.
Potential dosage forms include tablets, capsules, powders, oral liquids, syrups, creams, ointments, gels, suppositories and other specialized delivery systems.
Botanical extracts can present formulation challenges including poor water solubility, hygroscopicity, unpleasant taste or odour, poor flow, variable particle size, instability and incompatibility with excipients. Some preparations may also contain constituents that are sensitive to heat, light, oxygen or moisture.
Herbaceutic formulation therefore requires careful selection of excipients and processing methods. Parameters such as particle characteristics, moisture content, extract concentration, compression behaviour, disintegration, dissolution and storage stability may need to be evaluated.
Drug-delivery technologies may offer additional opportunities where conventional dosage forms do not provide adequate performance. Depending on the specific product, technologies involving microencapsulation, nanoformulation, lipid-based systems or other controlled-delivery approaches may be investigated.
Such technologies should not be adopted merely because they are technologically advanced. Their use should be justified by a clearly defined product-development objective and supported by appropriate evidence of safety, stability and performance.
The fundamental purpose of Herbaceutic formulation is therefore not technological complexity but controlled and appropriate delivery of the botanical preparation.
6. Quality by Design in Herbal Medicine
Quality by Design (QbD) provides a systematic methodology for developing products in which quality is deliberately built into the formulation and manufacturing process rather than tested only at the end.
Its application to herbal medicines is particularly relevant because botanical materials and preparations can exhibit substantial natural variability.
A QbD-oriented approach begins with the definition of the Quality Target Product Profile (QTPP). This establishes the intended characteristics of the finished product, including dosage form, route of administration, strength, stability and relevant performance requirements.
Critical Quality Attributes (CQAs) can then be identified. Depending on the product, these may include identity, marker-compound content, chemical fingerprint, microbial quality, moisture, dissolution, physical characteristics and stability.
Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) are subsequently investigated to understand how raw materials and manufacturing processes influence CQAs.
Risk assessment, design of experiments and process understanding can help identify important relationships and establish robust formulation and manufacturing conditions.
For herbal products, QbD can therefore provide a structured means of managing variability without attempting to eliminate the inherent biological complexity of medicinal plants.
QbD should be regarded as a development methodology within Herbaceutics, rather than as a replacement for Herbaceutics itself.
7. Advanced Analytical and Digital Approaches
Rapid advances in analytical science are expanding the ability to characterize medicinal plants and complex herbal preparations.
Chromatographic and spectroscopic techniques remain central to quality evaluation, while metabolomics can provide broader profiles of chemical constituents. DNA-based authentication can assist in verifying botanical identity, particularly where morphological identification is difficult.
Fingerprinting approaches can provide characteristic patterns that facilitate comparison among batches and help detect substitution or adulteration.
Computational approaches and artificial intelligence may further support pattern recognition, prediction of formulation behaviour, identification of potential bioactive constituents and analysis of complex datasets. Digital tools may also assist in traceability throughout cultivation, processing and manufacturing.
These technologies are most valuable when integrated into a scientifically coherent development strategy. Analytical sophistication does not by itself establish therapeutic efficacy. Instead, advanced analytical methods should support the broader objectives of identity, quality, reproducibility, safety and product understanding.
8. Safety and Herb–Drug Interactions
The perception that natural products are inherently safe can create significant risks. Medicinal plants contain biologically active substances capable of producing therapeutic as well as adverse effects.
Safety evaluation should therefore consider acute and chronic toxicity, organ-specific effects, reproductive and developmental toxicity where relevant, genotoxicity and other potential risks according to the intended use and exposure.
Herb–drug interactions are particularly important in patients receiving conventional medicines. Interactions may arise through effects on drug-metabolizing enzymes, transporters, gastrointestinal absorption, pharmacodynamic pathways or other mechanisms.
Risk assessment should take account of dose, duration of use, preparation type, patient characteristics and concomitant medicines.
Formulation may also influence exposure. Differences in extraction efficiency, concentration, dissolution and bioavailability can alter the amount of biologically active constituents reaching systemic or local sites of action.
Appropriate product labelling, professional education, pharmacovigilance and communication with patients are therefore essential components of responsible herbal medicine use.
9. Traditional Knowledge and Clinical Evidence
Traditional knowledge represents an important source of information for medicinal-plant research. It can guide the selection of species, plant parts, preparation methods and therapeutic applications.
However, the scientific evaluation of traditional knowledge requires methodological care. Historical use should not automatically be equated with clinical efficacy, nor should the absence of conventional clinical evidence necessarily be interpreted as proof of ineffectiveness.
A progressive evidence framework can include ethnomedical documentation, botanical authentication, phytochemical characterization, in vitro investigation, animal studies, toxicological evaluation, pharmacokinetic studies and appropriately designed human clinical studies.
Clinical research should address questions relevant to the intended product and indication. Where feasible, randomized controlled trials can provide important evidence regarding efficacy and safety. Observational studies, pragmatic research and real-world evidence can provide complementary information concerning patterns of use and longer-term experience.
An important consideration is that clinical evidence should correspond to the actual preparation being used. Evidence generated from one extract or formulation cannot automatically be transferred to a substantially different preparation.
This reinforces the importance of Herbaceutic reproducibility: the product evaluated scientifically should correspond sufficiently to the product ultimately administered to patients.
10. Medicinal Plants in Integrative Healthcare
Integrative healthcare seeks to bring together appropriate conventional and complementary approaches within a coordinated framework centred on patient needs, safety and evidence.
Medicinal plants can contribute to such systems where there is adequate evidence for their intended applications and appropriate safeguards concerning quality, dosage and interactions.
Integration requires communication among healthcare professionals. Pharmacists, physicians, nurses, herbal medicine practitioners and other relevant professionals should understand the potential benefits, limitations and risks of herbal products.
From a pharmaceutical perspective, reliable dosage forms and clear product information can facilitate appropriate use. Patients should be encouraged to disclose their use of herbal products, particularly when receiving prescription medicines or undergoing procedures.
The future of integrative healthcare therefore depends not simply on increasing the availability of herbal products but on improving their quality, evidence base, transparency and compatibility with responsible clinical practice.
11. Global Opportunities for Medicinal Plant-Based Pharmaceutical Development
The growing global interest in medicinal plants presents an opportunity to strengthen the transition from traditional botanical remedies to scientifically characterized, quality-assured and clinically relevant herbal medicines. This opportunity extends across Africa, Asia, Europe, the Americas and other regions where medicinal plants remain important components of healthcare, pharmaceutical research and cultural heritage.
A major opportunity lies in integrating traditional knowledge with contemporary pharmaceutical science. Traditional use can provide valuable leads for identifying medicinal species, therapeutic indications and preparation methods. However, traditional use alone does not establish consistent composition, safety, dosage or clinical effectiveness. Herbaceutic development can provide a structured pathway through which promising botanical preparations are authenticated, characterized, formulated and evaluated.
Global collaboration is particularly important because medicinal-plant research is inherently multidisciplinary and geographically diverse. Partnerships among pharmacognosists, phytochemists, pharmacists, formulation scientists, pharmacologists, clinicians, toxicologists, botanists, ethnomedical practitioners, regulators and industry can accelerate translation of promising plants into appropriate medicinal products.
There is also considerable potential for local and regional pharmaceutical manufacturing. Countries rich in medicinal-plant resources can move beyond the export of raw botanical materials towards the development of standardized extracts, finished dosage forms and evidence-supported phytopharmaceutical products. Such development can contribute to pharmaceutical self-reliance, economic diversification, employment and improved access to locally relevant healthcare products.
Technological advances are expanding these opportunities. Modern analytical chemistry, metabolomics, molecular authentication, advanced extraction technologies, computational approaches and novel drug-delivery systems can improve the characterization and reproducibility of botanical medicines.
An important objective is the development of regionally appropriate but internationally compatible herbal medicines. Botanical resources, traditional practices and healthcare systems differ among populations. A globally relevant Herbaceutic framework should therefore not impose a single model on all medicinal-plant systems. Instead, it should provide common scientific principles—identity, quality, safety, reproducibility, appropriate formulation and evidence—while allowing legitimate regional differences.
Regulatory cooperation is another important opportunity. Differences in definitions, quality requirements, evidence standards, permitted claims and registration pathways can complicate the international development and movement of herbal medicinal products. Greater cooperation among regulators, researchers and industry could promote convergence of scientific and quality expectations while respecting national and regional regulatory requirements.
Sustainability must remain integral to medicinal-plant development. Increasing commercial demand can place pressure on wild populations and ecosystems. Sustainable cultivation, responsible collection, traceability, biodiversity conservation and equitable benefit-sharing are therefore essential components of responsible innovation.
The global opportunity is ultimately not simply to increase the number of herbal products available in the marketplace. It is to improve their quality, reproducibility, safety, acceptability and therapeutic usefulness.
Herbaceutics can contribute to this objective by providing a formulation-centred bridge between botanical resources, pharmaceutical science and patient use. Its international relevance lies in its adaptability: botanical materials and regulatory environments may differ across regions, but the fundamental challenge remains similar—transforming complex biological materials into reliable medicinal products without losing sight of their biological, cultural and ecological context.
12. Sustainability, Biodiversity and Traditional Knowledge
Medicinal-plant development must be compatible with ecological sustainability and responsible use of biological resources.
Unsustainable harvesting may threaten plant populations and biodiversity, particularly when demand increases rapidly following the commercialization of a medicinal species.
Cultivation can provide an alternative to uncontrolled wild collection, although cultivation itself requires appropriate management of soil, water, genetic diversity, pesticides and other agricultural inputs.
Good Agricultural and Collection Practices can support consistent raw-material quality while promoting responsible resource management.
Traceability is also important. The ability to identify the geographical and production history of a botanical material can support quality assurance, supply-chain management and sustainability.
Traditional knowledge presents an additional ethical dimension. Communities that have developed and maintained knowledge concerning medicinal plants should not be excluded from benefits arising from its commercial or scientific utilization. Appropriate legal and ethical frameworks for access, benefit-sharing and protection of traditional knowledge are therefore important.
Sustainable medicinal-plant development should consequently seek a balance among therapeutic innovation, biodiversity conservation, economic opportunity and cultural responsibility.
13. Regulatory Science
Regulation is essential for ensuring that herbal medicinal products meet appropriate standards of quality, safety and, where applicable, efficacy.
Regulatory systems differ internationally in how they classify and evaluate herbal products. Depending on jurisdiction, a botanical product may be regulated as a traditional medicine, herbal medicinal product, dietary or health supplement, phytopharmaceutical or another category.
Such differences influence requirements for evidence, manufacturing, quality control, labelling, claims and registration.
For manufacturers and researchers, regulatory considerations should be incorporated early rather than treated as an end-stage activity. Product development should anticipate relevant requirements concerning botanical identity, specifications, contaminants, stability, manufacturing controls, documentation and clinical evidence.
Harmonization of scientific principles may facilitate international development while allowing regulatory authorities to maintain jurisdiction-specific requirements.
Herbaceutics can support regulatory science by strengthening the connection between formulation design, critical quality attributes, manufacturing processes, stability and finished-product specifications.
14. Integrated Herbaceutic Plant-to-Product Development Framework
An effective medicinal-plant development programme can be organized into a continuous framework:
Ethnomedical/Scientific Identification → Authentication and Sustainable Sourcing → Preparation Development → Pharmacological and Safety Evaluation → Herbaceutic Formulation → Stability and Manufacturing → Clinical and Regulatory Translation → Commercialization and Pharmacovigilance
Stage 1: Ethnomedical and Scientific Identification
Potential medicinal plants are identified through traditional knowledge, ethnobotanical investigation, scientific literature, pharmacological screening or other discovery approaches.
Stage 2: Authentication and Sustainable Sourcing
The botanical identity is established, the appropriate plant material is selected and sourcing is controlled through appropriate agricultural or collection practices.
Stage 3: Raw-Material and Preparation Development
Processing, drying, extraction and preparation methods are investigated and controlled to produce a sufficiently characterized botanical preparation.
Stage 4: Pharmacological and Safety Evaluation
The biological activity, preliminary mechanism, dose-response characteristics and relevant safety profile are investigated using appropriate experimental models.
Stage 5: Herbaceutic Formulation and Optimization
This is the core Herbaceutic stage. The botanical preparation is transformed into an appropriate dosage form, taking into account its physicochemical and biological characteristics, intended dose, route, stability, acceptability, manufacturability and desired delivery characteristics.
Stage 6: Stability, Manufacturing and Scale-Up
The formulation and manufacturing process are optimized for reproducibility, stability and scalable production. Appropriate in-process and finished-product controls are established.
Stage 7: Clinical and Regulatory Translation
The product is evaluated in appropriate human studies and developed in accordance with applicable regulatory requirements.
Stage 8: Commercialization, Pharmacovigilance and Continuous Improvement
Following appropriate authorization, the product enters controlled distribution and use. Safety monitoring, product-quality surveillance, consumer feedback and emerging scientific evidence contribute to continuous improvement.
The framework emphasizes that the medicinal plant is the starting material, not the finished medicine.
It also clarifies the position of Herbaceutics within the wider development process. Herbaceutics does not replace botanical identification, pharmacological research, clinical investigation or regulatory science. Its principal contribution is the scientifically controlled transformation of a characterized botanical preparation into a suitable medicinal dosage form.
15. Future Perspectives
The future of herbal medicine will increasingly depend on the ability to combine the strengths of traditional knowledge with rigorous pharmaceutical and biomedical science.
Several developments are likely to shape the field.
First, advances in analytical science will improve the characterization of complex botanical preparations. Second, computational methods and artificial intelligence may facilitate the interpretation of large phytochemical, pharmacological and clinical datasets. Third, novel drug-delivery technologies may improve the performance of selected herbal preparations.
Fourth, greater attention will likely be directed towards the relationship between chemical composition and biological activity. Rather than focusing exclusively on isolated marker compounds, future research may increasingly investigate multidimensional chemical and biological signatures.
Fifth, personalized and precision-oriented approaches could eventually influence herbal medicine, particularly where genetic, metabolic or microbiome-related differences affect therapeutic response. Such applications, however, require substantial evidence before routine clinical implementation.
The field will also need stronger international collaboration. Shared reference materials, validated analytical methods, standardized terminology, interoperable datasets and collaborative clinical research could improve comparability among studies and products.
Education will be equally important. Pharmaceutical and healthcare curricula should provide appropriate understanding of botanical medicines, including their quality characteristics, evidence, safety considerations, formulation and potential interactions.
Within this evolving landscape, Herbaceutics has an opportunity to develop as a recognizable scientific discipline focused on the unique formulation and dosage-form challenges of botanical medicines.
16. Key Research Priorities
Future research in Herbaceutics and medicinal-plant pharmaceutical development should address several priority areas:
1. Botanical authentication and traceability using complementary morphological, chemical and molecular methods.
2. Understanding sources of variability from genetics and cultivation through harvesting, processing and extraction.
3. Development of robust standardization strategies that integrate chemical and, where appropriate, biological characteristics.
4. Advanced herbal dosage-form development addressing stability, solubility, bioavailability, patient acceptability and manufacturability.
5. Application of Quality by Design to improve formulation and manufacturing robustness.
6. Validation of advanced analytical and computational methods for complex botanical preparations.
7. Systematic investigation of safety and herb–drug interactions, particularly for products likely to be used alongside conventional medicines.
8. Well-designed clinical studies using clearly characterized and reproducible preparations.
9. Long-term pharmacovigilance and real-world evidence generation following market introduction.
10. Sustainable cultivation and responsible sourcing to protect medicinal-plant biodiversity.
11. International collaboration and regulatory convergence to facilitate responsible development and appropriate access to quality herbal medicines.
12. Development of Herbaceutics as an academic and professional field, including appropriate terminology, curricula, research methodologies and competency standards.
These priorities should be pursued collaboratively rather than in disciplinary isolation. The complexity of medicinal plants makes interdisciplinary research particularly important.
17. Conclusion
Medicinal plants remain an important source of therapeutic knowledge and pharmaceutical potential. Their continued relevance, however, depends on the ability to address the scientific, technological, clinical, regulatory and sustainability challenges associated with converting complex botanical materials into reliable medicines.
The central challenge is not simply discovering medicinal plants or demonstrating that a plant contains biologically active constituents. It is establishing a controlled pathway through which botanical identity, preparation, composition, formulation, dosage, stability, safety and therapeutic performance can be connected.
Herbaceutics—the science and art of herbal dosage-form design and formulation—provides an important contribution to this challenge. Its distinctive role lies in creating the formulation and dosage-form bridge between a characterized botanical preparation and a reproducible medicinal product.
This perspective does not diminish the importance of pharmacognosy, phytochemistry, pharmacology, toxicology, clinical medicine or conventional pharmaceutics. Rather, it provides an interface through which these disciplines can contribute to the development of herbal medicines.
The future of medicinal-plant healthcare should therefore move beyond the simple dichotomy between “traditional” and “modern.” The more productive objective is a scientifically integrated continuum in which traditional knowledge can inform discovery, botanical science establishes identity and quality, pharmacological and clinical sciences generate evidence, and Herbaceutics translates characterized botanical preparations into appropriate medicinal dosage forms.
Ultimately, the medicinal plant is the starting material, not the finished medicine.
The successful transformation of botanical therapeutic potential into safe, effective, reproducible and patient-acceptable products will require not only better plants and better science, but also better formulation thinking. Herbaceutics provides a framework for that formulation thinking and, consequently, has the potential to become an important component of the future scientific development of herbal medicine.
PS: Livy-Elcon Emereonye is the propounder of Herbaceutics
References
1. World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organization; 2019.
2. World Health Organization. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: World Health Organization; 2003.
3. World Health Organization. WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: World Health Organization; 2007.
4. World Health Organization. Quality Control Methods for Herbal Materials. Geneva: World Health Organization; 2011.
5. World Health Organization. WHO Traditional Medicine Strategy 2014–2023. Geneva: World Health Organization; 2013.
6. Heinrich M, Barnes J, Gibbons S, Williamson EM. Fundamentals of Pharmacognosy and Phytotherapy. 2nd ed. Edinburgh: Churchill Livingstone Elsevier; 2012.
7. Evans WC. Trease and Evans' Pharmacognosy. 16th ed. Edinburgh: Saunders Elsevier; 2009.
8. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnology Advances. 2015;33(8):1582–1614.
9. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 1981 through 2019. Journal of Natural Products. 2020;83(3):770–803.
10. Pan SY, Litscher G, Gao SH, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evidence-Based Complementary and Alternative Medicine. 2014;2014:525340.
11. Li FS, Weng JK. Demystifying traditional herbal medicine with modern approach. Nature Plants. 2017;3:17109.
12. Mukherjee PK. Quality Control and Evaluation of Herbal Drugs: Evaluating Natural Products and Traditional Medicine. 2nd ed. Elsevier; 2019.
13. Bandaranayake WM. Quality control, screening, toxicity, and regulation of herbal drugs. In: Ahmad I, Aqil F, Owais M, editors. Modern Phytomedicine: Turning Medicinal Plants into Drugs. Weinheim: Wiley-VCH; 2006. 


Introduction
Every year on August 31, the African Region commemorates African Traditional Medicine Day, providing an opportunity to acknowledge the historical, cultural, scientific and public-health significance of traditional medicine across the continent.
The 2026 theme, “Reflection on Research and Development Efforts of Traditional Medicine Towards Achieving Universal Health Coverage in the African Region,” is particularly timely. It challenges Africa to move beyond simply acknowledging traditional medicine as part of its cultural heritage and to critically examine how research, innovation, regulation and responsible integration can transform its potential into measurable health benefits.
Traditional medicine remains an important component of healthcare in many African communities. The World Health Organization (WHO) recognises that traditional, complementary and integrative medicine is used by millions of people globally and can contribute to health and wellbeing when appropriately regulated and supported by evidence.
In Africa, traditional medicine is particularly relevant because healthcare access remains uneven. Distance to health facilities, cost, shortages of health workers, inadequate infrastructure and cultural preferences influence where and how people seek care.
Consequently, the central question should no longer be whether traditional medicine has a place in African healthcare. It already occupies one.
The more important questions are: What works? What does not work? What is safe? What is effective? How should quality be assured? What traditional practices can be scientifically validated? How can promising medicinal resources be developed into standardised health products? And how can proven interventions contribute appropriately to Universal Health Coverage (UHC)?
These are fundamentally questions of research and development (R&D).
Traditional Medicine and Africa's Public-Health Reality
Africa continues to confront a complex combination of communicable and non-communicable diseases, maternal and child health challenges, nutritional disorders, emerging infections and increasing demands associated with ageing and chronic disease.
At the same time, health systems in many countries face persistent constraints involving financing, infrastructure, human resources, medicine availability and equitable access.
Traditional medicine has consequently remained an accessible source of healthcare for many communities.
Its importance derives partly from its proximity, affordability, cultural acceptability and community embeddedness. Traditional health practitioners are often members of the communities they serve and may be consulted before, alongside or instead of conventional healthcare providers.
This reality creates both an opportunity and a responsibility.
Ignoring traditional medicine does not make its use disappear. Instead, it can create a parallel system operating with inadequate documentation, inconsistent quality assurance and insufficient safety surveillance.
Public health therefore requires an evidence-informed approach.
Traditional medicine should neither be romanticised nor dismissed. Its practices and products should be evaluated according to the same fundamental public-health principles that apply to other health interventions: quality, safety, efficacy, effectiveness, affordability, equity and appropriateness.
From Indigenous Knowledge to Scientific Evidence
Africa possesses an extraordinary body of indigenous knowledge concerning medicinal plants, foods, therapeutic practices and approaches to health and wellbeing.
This knowledge represents an important intellectual and cultural resource.
However, traditional knowledge is vulnerable to loss. As generations change and traditional knowledge holders age, valuable information can disappear unless systematically documented and preserved.
Documentation should therefore form an important part of African traditional medicine research.
But documentation should not become exploitation.
Indigenous communities and traditional knowledge holders should be recognised as stakeholders and partners. Research involving indigenous knowledge should observe ethical requirements concerning prior informed consent, intellectual property, ownership, confidentiality where appropriate and equitable benefit-sharing.
Scientific research can subsequently investigate promising traditional practices using appropriate methodologies.
This may include ethnobotanical research, phytochemical analysis, pharmacological investigation, toxicological assessment, formulation development, preclinical studies and clinical trials.
Clinical Research: The Critical Missing Link
One of the major challenges facing traditional medicine is the limited availability of high-quality clinical evidence for many interventions.
Laboratory findings are important, but laboratory activity does not automatically translate into clinical effectiveness.
An extract may demonstrate biological activity in vitro without producing a meaningful therapeutic effect in humans. Conversely, a complex traditional preparation may have effects that require more sophisticated research designs to understand.
Clinical research is therefore essential.
Appropriately designed studies can investigate:
- efficacy and effectiveness;
- dosage and treatment duration;
- adverse effects;
- drug-herb interactions;
- contraindications;
- vulnerable populations;
- long-term safety; and
- real-world effectiveness.
Africa should strengthen its capacity to conduct such research within African populations and according to African health priorities.
Research questions should reflect the continent's actual disease burden and healthcare needs rather than being driven exclusively by external commercial interests.
Safety Must Remain Non-Negotiable
A scientifically responsible approach to traditional medicine must place patient safety at the centre.
The assumption that something is safe because it is “natural” is scientifically incorrect.
Medicinal plants contain pharmacologically active compounds. Those compounds may produce beneficial effects, adverse effects or both.
Traditional medicinal products may also be affected by problems involving incorrect plant identification, contamination, adulteration, inappropriate preparation, variable dosage or unsafe storage.
Potential interactions between herbal medicines and pharmaceutical drugs are another important concern, particularly among patients who use multiple healthcare systems simultaneously.
For this reason, Africa needs stronger systems for:
quality assurance, adverse-event reporting, pharmacovigilance, laboratory testing, product surveillance and practitioner regulation.
Scientific research must therefore investigate risks as carefully as it investigates benefits.
The purpose of science is not to prove a predetermined position. It is to establish what is true—or most strongly supported by evidence—and to identify the circumstances under which an intervention can be used safely and effectively.
Building African Research Capacity
If Africa is serious about harnessing traditional medicine for UHC, investment in research capacity is essential.
This includes laboratories, clinical research facilities, analytical technologies, pharmaceutical-development capacity, regulatory science and appropriately trained researchers.
Universities and research institutions should encourage interdisciplinary programmes linking:
pharmacognosy, pharmacy, medicine, public health, pharmacology, toxicology, botany, chemistry, biotechnology, epidemiology, anthropology, health economics and health policy.
Young African scientists should be encouraged to investigate indigenous medicinal resources using contemporary scientific technologies.
This is more than a health investment.
It is also an investment in African scientific sovereignty.
Africa should increasingly become a producer of knowledge and health technologies rather than primarily a consumer of technologies developed elsewhere.
The Economic and Developmental Opportunity
Traditional medicine research also has an economic dimension.
Africa possesses substantial biological resources and indigenous knowledge but remains heavily dependent on imported medicines and pharmaceutical products.
Developing scientifically validated traditional medicine products could strengthen local value chains involving:
cultivation → sustainable harvesting → processing → extraction → formulation → quality assurance → manufacturing → distribution.
This could generate employment and support local industries.
However, commercialisation must be balanced with environmental sustainability.
Unsustainable harvesting can threaten medicinal plant populations and biodiversity. Conservation, therefore, must become an integral component of traditional medicine development.
Africa should invest in cultivation and sustainable production systems rather than relying exclusively on uncontrolled harvesting from the wild.
Protecting Indigenous Knowledge
As traditional medicine becomes increasingly commercialised and scientifically investigated, questions of ownership and benefit-sharing become more important.
Indigenous communities should not simply provide knowledge while external researchers or corporations capture the resulting economic benefits.
Research partnerships should incorporate mechanisms for recognition, consent, intellectual-property protection and equitable benefit-sharing.
The Nagoya Protocol on Access and Benefit-sharing provides an important international framework for addressing access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation.
Protecting indigenous knowledge is therefore not only an ethical responsibility; it can also encourage communities to participate actively in conservation, documentation and research.
Digital Technology and the Future
Digital technology offers additional opportunities.
African countries can develop digital repositories for medicinal plants and traditional knowledge, subject to appropriate safeguards. Artificial intelligence and computational approaches can support natural-product discovery and chemical analysis. Digital platforms can assist with practitioner education, research collaboration and pharmacovigilance.
However, technology must complement rather than replace scientific validation.
No algorithm can substitute for appropriate clinical evidence, ethical review, quality control and regulatory oversight.
A New African Research Agenda
The 2026 theme should stimulate a renewed African research agenda built around priority health needs.
Key priorities should include:
1. Systematic documentation and preservation of indigenous medical knowledge.
2. Scientific investigation of promising medicinal plants and traditional practices.
3. Standardisation and quality assurance of traditional medicine products.
4. Rigorous preclinical and clinical research.
5. Strengthening pharmacovigilance and safety surveillance.
6. Harmonisation of appropriate regulatory standards across countries.
7. Protection of indigenous knowledge and equitable benefit-sharing.
8. Sustainable cultivation and conservation of medicinal resources.
9. Development of African research and manufacturing capacity.
10. Health-economic research on affordability and cost-effectiveness.
11. Implementation research on responsible health-system integration.
12. Strengthened regional and international research collaboration.
Above all, research must progress beyond publication to translation.
A discovery that remains confined to a laboratory or academic journal has limited population-health impact.
Discovery must lead to translation, and translation must ultimately lead to improved health outcomes.
From Celebration to Transformation
African Traditional Medicine Day should therefore be more than an annual ceremonial event.
It should become an opportunity for reflection, accountability and action.
Africa should ask:
How much is being invested in traditional medicine research?
How many promising discoveries have progressed from laboratory research to clinical evaluation?
How many traditional medicine products meet appropriate quality standards?
How effective are pharmacovigilance systems?
How much indigenous knowledge is being systematically preserved?
How much value is Africa capturing from its own medicinal biodiversity?
And perhaps most importantly:
How much of this research is actually improving the health and wellbeing of African populations?
These questions matter because the ultimate measure of research is not the number of papers published, but the knowledge generated, innovations developed, lives improved and inequalities reduced.
Conclusion
The 2026 African Traditional Medicine Day theme, “Reflection on Research and Development Efforts of Traditional Medicine Towards Achieving Universal Health Coverage in the African Region,” provides Africa with an opportunity to rethink the place of traditional medicine in contemporary healthcare.
Africa cannot afford to ignore credible opportunities to improve access to safe, effective, affordable and culturally acceptable healthcare.
Traditional medicine represents one such opportunity—but its future must be guided by evidence rather than sentiment; science rather than speculation; regulation rather than unrestrained commercialisation; sustainability rather than exploitation; and partnership rather than polarisation.
The objective should not be to prove that traditional medicine is superior to conventional medicine, nor to establish that conventional medicine is inherently superior to traditional medicine.
The objective should be to determine, through rigorous research and responsible public-health practice, what works, what is safe, what is affordable, what is culturally appropriate and how proven interventions can contribute to better health outcomes.
Africa possesses an extraordinary inheritance of indigenous medical knowledge and biological resources.
The responsibility of the present generation is to ensure that this inheritance is neither lost through neglect nor exploited through irresponsible commercialisation.
It should be documented, scientifically investigated, validated where appropriate, standardised, regulated, sustainably developed and translated into health solutions that serve humanity.
Universal Health Coverage requires health systems capable of combining access, quality, affordability, safety, equity and innovation.
Traditional medicine can contribute to that vision—but only through a deliberate commitment to research, development, responsible integration and continuous evaluation.
As Africa commemorates African Traditional Medicine Day 2026, the message should therefore be unequivocal:
Africa must not merely preserve its traditional medicine heritage. It must research it, validate it, regulate it, innovate through it and responsibly harness its proven potential for the health and wellbeing of present and future generations.
Happy African Traditional Medicine Day 2026!
PS: Dr. Emereonye could be reached on: +234 803 3922 445
REFERENCES
1. World Health Organization (WHO). WHO Traditional Medicine Strategy: 2014–2023. Geneva: World Health Organization; 2013.
https://www.who.int/publications/i/item/9789241506096
2. World Health Organization (WHO). Global Traditional Medicine Strategy 2025–2034. Geneva: World Health Organization; 2025.
https://www.who.int/publications/i/item/9789240117137
3. World Health Organization Regional Office for Africa. Traditional Medicine Strategy 2013–2023. Brazzaville: WHO Regional Office for Africa.
https://www.afro.who.int/publications/regional-strategy-traditional-medicine-2013-2023
4. World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organization; 2019.
https://www.who.int/publications/i/item/978924151536
5. World Health Organization. Traditional Medicine. WHO Fact Sheet. Geneva: World Health Organization.
https://www.who.int/news-room/questions-and-answers/item/traditional-medicine
6. World Health Organization. Universal Health Coverage (UHC). Geneva: World Health Organization.
https://www.who.int/health-topics/universal-health-coverage
7. World Health Organization Regional Office for Africa. The State of Health in the African Region. Brazzaville: WHO Regional Office for Africa.
https://www.afro.who.int/
8. World Health Organization. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: World Health Organization; 2003.
https://www.who.int/publications/i/item/9241546271
9. World Health Organization. WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: World Health Organization; 2007.
https://www.who.int/publications/i/item/9789241594448
10. United Nations. Convention on Biological Diversity: Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization. Montreal: Secretariat of the Convention on Biological Diversity; 2011.
https://www.cbd.int/abs/
11. Petrovska BB. Historical review of medicinal plants' usage. Pharmacognosy Reviews. 2012;6(11):1–5.
https://doi.org/10.4103/0973-7847.95849
12. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives. 2001;109(Suppl 1):69–75.
https://doi.org/10.1289/ehp.01109s169
13. Calixto JB. Twenty-five years of research on medicinal plants in Latin America: a personal view. Journal of Ethnopharmacology. 2005;100(1–2):131–134.https://doi.org/10.1016/j.jep.2005.06.004
14. World Health Organization. WHO Guidelines for the Assessment of Herbal Medicines. Geneva: World Health Organization.
https://www.who.int/
15. United Nations. Transforming our World: The 2030 Agenda for Sustainable Development. New York: United Nations; 2015. https://sdgs.un.org/2030agenda
There is an irony that has quietly settled over human civilization like the evening mist over an ancient valley. It is the irony of people who spend the greater part of their lives wrestling over keys while ignoring the opportunity to build the entire house. They quarrel over seats while neglecting the wisdom of manufacturing chairs. They exhaust themselves competing for borrowed influence when destiny has already placed within them the raw materials for creating enduring relevance.
Indeed, it doesn't make sense fighting for a stadium when one can own the community.
The statement sounds mischievous. It provokes a smile before it provokes a thought. Like many timeless proverbs, it arrives dressed in simplicity but carries within it the weight of generations of wisdom. It is satire with a surgical blade. It laughs at our misplaced ambitions while exposing one of the greatest philosophical errors of mankind—the tendency to confuse visibility with value, position with purpose, and applause with accomplishment.
Modern society has perfected the art of celebrating the occupant of the stage while forgetting the architect who designed the theatre. We applaud the footballer who scores the winning goal, yet scarcely remember the entrepreneur who built the stadium, the engineer who designed it, the scientist whose innovations made the floodlights possible, or the farmer whose harvest fed both spectators and players. The crowd naturally looks upward toward the performer, while history quietly bows before the creator.
The tragedy of many lives is not the absence of talent. It is the misdirection of talent. Rivers do not become oceans because they possess more water than every stream; they become oceans because they know where they are going. Direction is often more powerful than speed. A man running in the wrong direction only arrives at irrelevance faster.
How many gifted people spend decades fighting battles they were never designed to fight? How many brilliant minds waste priceless years chasing titles whose glamour evaporates with the ink of a retirement letter? How many extraordinary individuals become ordinary because they measure success by another person's tape?
Nature has always preached a sermon that humanity seldom listens to. The eagle never apologizes because it cannot swim like the dolphin. The whale does not envy the antelope because it cannot outrun it. The palm tree never competes with the bamboo over height, nor does the sunflower envy the rose because their seasons of beauty differ. Every creature understands its ecological assignment—except man, who often mistakes imitation for ambition.
There is something profoundly comical about watching a fish campaigning to become the king of birds. Equally absurd is watching an eagle lament that it cannot breathe underwater. Yet this is precisely what many educated people do every day. They abandon the territories where excellence awaits them and invade arenas where mediocrity is guaranteed.
The marketplace has become crowded not because there are too many gifted people, but because too many gifted people are selling the same commodity. Originality has become endangered, while imitation has become fashionable. Entire generations now queue at the same narrow gate, pushing and shoving one another for opportunities that were never meant to accommodate everyone.
Meanwhile, unexplored frontiers lie quietly waiting for pioneers.
History has always rewarded pioneers more generously than competitors.
Christopher Columbus did not become famous because he sailed better than everyone else. He became memorable because he sailed where others feared to venture. Thomas Edison did not merely improve darkness; he challenged its permanence. The Wright brothers refused to believe that gravity possessed the final vote over human destiny. Every significant advancement in civilization began when someone abandoned the crowded road and created another.
That is the invisible power of discovering one's niche.
Your niche is not merely what you are trained to do. It is the sacred intersection where your gifts, your convictions, your experiences, your burdens, your passions, and humanity's needs converge. It is the address where your usefulness resides. It is the geographical location of your destiny.
Many people search for success while success patiently waits inside their purpose.
A mango seed never becomes an iroko tree, not because it lacks life, but because life has already defined its assignment. Every seed carries within itself an invisible blueprint. Likewise, every human being arrives on earth carrying a unique architecture of possibility. The tragedy is that many die as photocopies of others instead of becoming the original manuscripts they were born to be.
One of the most expensive mistakes in life is spending your strength improving a weakness while neglecting the gift that could have transformed generations. There is wisdom in development, but there is greater wisdom in specialization. Society remembers those who solved problems, not those who merely participated in activities.
A man may know a little about everything and still become unforgettable for mastering one thing.
Gold is valuable because it is scarce.
Diamonds command attention because they are rare.
Excellence derives its market value from focused refinement.
The temptation to become everything to everybody has produced countless nobodies. A candle that tries to illuminate the whole city ends up extinguishing itself. Even the sun, magnificent as it is, shines from one position while lighting the entire earth. Influence does not require restlessness; it requires consistency.
Life repeatedly teaches this lesson through ordinary experiences.
Visit any marketplace.
One trader sells vegetables.
Another repairs shoes.
A third specializes in mobile phones.
A fourth bakes bread.
Each prospers, not by selling everything, but by becoming known for something.
Ironically, the customer who wants everything from one shop often leaves disappointed. Trust grows where specialization lives.
The same principle governs leadership, scholarship, entrepreneurship, and nation-building.
Nations rise because individuals discover their comparative advantages. Japan mastered precision. Switzerland became synonymous with quality. Silicon Valley cultivated innovation. Every enduring civilization identified its strengths and multiplied them instead of dissipating energy chasing every passing fashion.
Individuals are governed by the same law.
The lawyer who understands negotiation creates influence beyond the courtroom.
The physician who dedicates himself to research changes medicine for generations.
The teacher who ignites curiosity lives forever in the achievements of former students.
The pharmacist who refuses to remain behind the dispensing counter and instead pioneers new frontiers in pharmaceutical innovation creates an ecosystem where others merely sought employment.
The difference between significance and survival often lies in recognizing where one can create value rather than where one can merely occupy space.
And here lies the hidden satire of our age.
Too many people are fighting over the microphone while ignoring the ownership of the broadcasting station.
They celebrate the ribbon-cutting ceremony but overlook the years of planning that made the ceremony possible.
They envy crowns without understanding the burdens that forged the king.
The loudest applause is usually reserved for the visible performer, but the deepest gratitude belongs to the invisible builder.
Life quietly whispers a timeless truth to those willing to listen:
Do not merely ask where the crowd is gathering.
Ask where the future is waiting to be built.
For there comes a point when the wise cease struggling for admission into someone else's stadium and begin laying the foundations of an entire community.
And that is where true greatness begins.
The Alchemy of Obstacles and the Majesty of Purpose
Every generation inherits two marketplaces.
The first is noisy.
The second is silent.
The noisy marketplace is crowded with competitors. It is filled with elbows, accusations, desperate ambitions, political intrigues, unnecessary rivalries and endless comparisons. Everybody wants the same office, the same title, the same recognition and the same applause. Here, success is measured by how many people one defeats.
The silent marketplace is different.
There, inventors are thinking.
Researchers are experimenting.
Entrepreneurs are building.
Teachers are moulding.
Farmers are cultivating.
Scientists are discovering.
Philosophers are questioning.
Visionaries are creating tomorrow while the crowd argues about yesterday.
Ironically, history has always promoted those who chose the silent marketplace.
While Rome was entertaining itself in magnificent arenas, unknown engineers were quietly building aqueducts that sustained civilizations. While kings fought over territories, blacksmiths forged the weapons, carpenters built the ships, and anonymous craftsmen erected monuments that outlived their patrons. Time possesses an unusual sense of humour. It often immortalizes the builder while quietly forgetting the quarrels of those who fought over temporary privileges.
Life itself is a relentless teacher of this philosophy.
Observe the village blacksmith.
His workshop is never as glamorous as the chief's palace. His hands are stained with soot, his clothes smell of iron, and his face bears the marks of honest labour. Yet when the farmer needs a cutlass, the hunter requires a trap, or the warrior demands a spear, they all return to the blacksmith.
The palace may command authority.
The workshop commands necessity.
And necessity has always outlived ceremony.
One of the greatest illusions of our age is the belief that visibility automatically translates into significance. Social media has magnified this deception. We count followers but ignore substance. We celebrate trends but neglect transformation. We admire those who occupy the front page while overlooking those quietly writing the future.
A tree never advertises its roots.
Yet every branch depends upon them.
The deepest contributions to humanity are often hidden beneath the surface.
The seed disappears before the harvest appears.
The foundation is buried before the skyscraper rises.
The womb remains unseen before the child is celebrated.
Invisible labour has always been the mother of visible greatness.
This is why obstacles should never be interpreted merely as inconveniences.
More often than not, they are invitations.
Every locked door silently asks whether you possess the creativity to design another entrance.
Every rejection asks whether your confidence depends upon human approval.
Every disappointment asks whether your dream belongs to the crowd or to your conviction.
Life has a curious habit of disguising opportunities as adversity. Unfortunately, most people judge the package before opening it.
When a sculptor looks at a rough stone, he does not see a rock. He sees a statue imprisoned within granite. Every strike of the chisel appears destructive to the casual observer, yet each blow is an act of liberation. The sculpture is not manufactured; it is revealed.
So it is with human destiny.
Adversity does not always destroy greatness.
Very often, it uncovers it.
History bears eloquent testimony.
The automobile emerged because humanity refused to remain dependent on horses.
Modern aviation was born because two bicycle mechanics dared to believe that gravity could be negotiated.
Countless life-saving medicines exist today because researchers refused to surrender to diseases that once appeared unconquerable.
Progress has always been the child of dissatisfaction.
Comfort has never produced civilization.
There is another lesson hidden within nature.
Consider the oyster.
The pearl it eventually produces begins as an irritation. A tiny grain of sand enters its shell and causes persistent discomfort. Instead of surrendering to irritation, the oyster transforms the nuisance into beauty. Layer upon layer, it coats the offending particle until the source of pain becomes an object of priceless value.
Human greatness follows the same pattern.
Some of the world's finest institutions were born out of frustration.
Many revolutionary businesses emerged from personal inconvenience.
Remarkable inventions began as someone's refusal to accept the status quo.
Sometimes your greatest opportunity arrives disguised as your greatest annoyance.
The obstacle is not your enemy.
Your interpretation of the obstacle may be.
This explains why two individuals can encounter the same difficulty and arrive at completely different destinations.
One complains.
The other creates.
One curses the darkness.
The other manufactures lanterns.
One sees unemployment.
Another establishes an industry that employs thousands.
One laments the collapse of a system.
Another builds a better one.
The difference rarely lies in circumstances.
It lies in perspective.
Perspective is the architect of destiny.
The farmer and the poet both look at the rain.
The farmer sees harvest.
The poet sees inspiration.
The engineer sees hydroelectric power.
The child sees puddles to play in.
Reality has not changed.
Only perception has.
This is why philosophy matters.
It teaches us not merely how to think, but what to notice.
And what we consistently notice eventually determines what we become.
Sadly, our educational systems have often rewarded conformity more than creativity. Students are trained to answer existing questions instead of discovering new ones. We produce excellent examinees but too few explorers. We celebrate certificates while neglecting curiosity. Yet civilization advances not because people memorize answers, but because someone dares to ask a question nobody else considered.
The greatest minds have always been unusually curious.
Isaac Newton did not invent gravity; he questioned what everyone else ignored.
Alexander Fleming did not plan to discover penicillin; he noticed what others would have discarded.
Innovation often begins where ordinary observation ends.
That is why every obstacle deserves careful examination.
Hidden inside every challenge is an unanswered question.
Whoever answers it first owns the opportunity.
The entrepreneur who solves traffic creates transportation systems.
The scientist who solves disease transforms healthcare.
The educator who solves ignorance shapes civilizations.
The communicator who solves misunderstanding builds peace.
The statesman who solves division writes history.
The niche you seek is frequently concealed within the problem that refuses to leave your heart.
Many spend years praying for opportunities while quietly walking past them every morning because opportunities rarely announce themselves with trumpets. They often arrive wearing the dusty clothes of hard work, uncertainty and inconvenience.
The miner does not complain that diamonds are hidden beneath the earth.
He understands that precious things are rarely found on the surface.
Likewise, extraordinary opportunities seldom reside in places where everyone is already comfortable.
This truth explains why genuine pioneers often appear eccentric before they become celebrated. Society initially laughs at unconventional ideas because familiarity is more comfortable than possibility. Yesterday's impossibility often becomes tomorrow's normality.
There was a time when speaking across continents without wires sounded absurd. There was a time when carrying a library in one's pocket belonged to the realm of fantasy. There was a time when surgery assisted by robots would have been dismissed as fiction.
Yet every modern convenience was once an unpopular idea protected by one determined mind.
That determined mind had discovered its community instead of competing for a stadium.
And therein lies the profound satire of life.
Many are exhausting themselves polishing the brass handle of a rented office, while others are quietly purchasing the entire building.
Some spend decades lobbying to become gatekeepers.
Others become city builders.
One group negotiates access.
The other creates access.
One fights over influence.
The other manufactures influence.
As the years unfold, history invariably reveals the difference.
For the world eventually bows—not before those who merely occupied positions—but before those who transformed problems into possibilities and opportunities into enduring legacies.
The Architecture of Legacy
There comes a defining moment in every life when the questions change.
In youth, we ask, "How do I get in?"
As maturity dawns, we begin to ask, "How do I stand out?"
But wisdom asks an entirely different question:
"How do I make this place better because I passed through it?"
That is the question that separates ambition from legacy.
Ambition seeks a position.
Legacy creates a platform.
Ambition counts followers.
Legacy raises leaders.
Ambition asks for recognition.
Legacy becomes indispensable.
The world has never been transformed merely by people who occupied offices. It has been transformed by men and women who occupied purpose. Offices are furnished with tables, chairs and plaques; purpose is furnished with vision, sacrifice and conviction. When the office expires, purpose continues its journey through the lives it has touched.
Consider the village well.
Nobody celebrates the mason who dug it every morning, yet generations draw water from his labour. Children who never knew his name drink because he thought beyond his own lifetime. Such is the quiet dignity of those who build communities instead of merely decorating stadiums.
Our age is fascinated by the spectacular. We admire the cutting of ribbons but seldom appreciate the years of planning, setbacks, redesigns and perseverance that made the ceremony possible. We applaud the fruit while forgetting the patient roots that wrestled silently beneath the soil. Yet the laws of life remain unchanged: every visible harvest is the public announcement of an invisible discipline.
The bamboo offers another lesson. For years it appears to do almost nothing above the ground. To the impatient observer, it seems unproductive. But beneath the surface it is weaving an intricate network of roots. Then, in what appears to be a sudden miracle, it shoots upward with astonishing speed. The miracle was never sudden. It had been preparing in silence.
So it is with purpose.
The years spent mastering a craft are never wasted.
The nights devoted to study are never lost.
The failures that refine judgment are never meaningless.
The disappointments that strengthen character are never accidental.
They are roots.
And roots do not compete with branches.
They sustain them.
This is why one must never despise seasons of obscurity. The world often mistakes silence for stagnation, but many destinies are being assembled behind curtains that applause cannot penetrate. A seed buried in the earth is not attending its funeral; it is preparing for its resurrection.
There is also a profound lesson in the carpenter's workshop. Before a magnificent piece of furniture emerges, the wood must first submit to the saw, the plane, the chisel and the sandpaper. Every tool appears hostile until the masterpiece is complete. Likewise, life's rough edges often become the instruments that polish extraordinary people.
The obstacle you resent today may become the testimony that defines you tomorrow.
The rejection that redirected your path may prove to be the greatest favour life ever granted you.
The closed door may have prevented you from entering a room too small for your destiny.
How often have we mourned opportunities that would have imprisoned our potential had they materialized? Providence sometimes says "no" because it is preparing a greater "yes." A wise traveller does not curse every detour; some roads are closed to prevent disaster, while others are opened to reveal a better destination.
The same principle applies to nations.
A country prospers not when every citizen seeks political office, but when every citizen discovers how to create value. A nation cannot survive on speeches alone. It needs inventors to innovate, farmers to cultivate, teachers to educate, healthcare professionals to heal, entrepreneurs to create wealth, artists to inspire, engineers to build, and thinkers to illuminate the path ahead.
Civilizations flourish when people major in what truly matters.
The orchestra becomes beautiful not because every musician plays the same instrument, but because each one masters a different instrument while following the same score. Uniformity produces noise; harmony produces music.
How tragic, then, when gifted individuals abandon their instruments simply because another section of the orchestra seems more glamorous. The violin envies the trumpet. The trumpet imitates the drum. The drum competes with the flute. In the end, everyone loses the symphony.
Purpose is not discovered by comparison.
It is discovered by conviction.
One of the greatest freedoms in life is the freedom to stop competing with everyone. The day you discover your niche, envy begins to lose its grip. Comparison becomes unnecessary. You cease measuring your worth by another person's achievements because you are no longer running another person's race. You become a builder, not a spectator; an architect, not merely an occupant.
And this is where obstacles assume an entirely different meaning.
The wall that stopped others becomes the foundation upon which you build.
The stone that caused others to stumble becomes the cornerstone of your enterprise.
The storm that uprooted weaker trees deepens your own roots.
The desert that frightened the faint-hearted teaches you where hidden wells can be found.
Life has an unusual habit of rewarding those who ask better questions. Instead of asking, "Why is this happening to me?" they ask, "What is this preparing me for?" Instead of asking, "Who closed the door?" they ask, "What door can I build?" Instead of asking, "Who will give me permission?" they ask, "What value can I create that makes permission irrelevant?"
These are the questions of community builders.
They are the questions of pioneers.
They are the questions that shape history.
When all is said and done, life will not merely examine the positions we occupied; it will examine the problems we solved. It will not ask how loudly we were applauded, but how deeply we served. It will not measure the number of stadiums in which we stood beneath the floodlights; it will measure the number of communities that became brighter because we chose to light a lamp instead of cursing the darkness.
And so, dear reader, before you expend another ounce of energy fighting over a seat, pause for a moment and look beyond the arena. Beyond the cheers lies the neighbourhood. Beyond the stadium lies the community. Beyond the title lies the legacy.
Perhaps your greatest calling is not to become the loudest voice in an existing conversation, but to begin a conversation that generations after you will still be having.
For the truly wise do not spend their lives struggling to become indispensable to an institution.
They build institutions that become indispensable to society.
They do not merely inherit platforms.
They create ecosystems.
They do not merely occupy history.
They author it.
And when the final chapter of their lives is written, the verdict is unmistakable: they understood that it never made sense to spend a lifetime fighting for a stadium when they possessed the vision, the courage, and the uncommon discipline to own the community.
PS: Dr. Emereonye could be reached on: +234 803 3922 445
Introduction
Every August, individuals, families, communities, healthcare professionals, and organizations around the world observe National Wellness Month, a dedicated period that promotes healthier lifestyles through intentional self-care, disease prevention, and the adoption of sustainable healthy habits. The 2026 National Wellness Month, observed from August 1 to August 31, reminds us that health is not merely the absence of disease but a dynamic state of complete physical, mental, emotional, and social well-being.
Modern society has witnessed remarkable advances in medicine, yet preventable diseases such as hypertension, diabetes mellitus, obesity, cardiovascular diseases, depression, anxiety disorders, chronic respiratory diseases, and several cancers continue to rise. Most of these illnesses are closely linked to unhealthy lifestyles, poor dietary habits, physical inactivity, chronic stress, inadequate sleep, tobacco use, and excessive alcohol consumption.
The encouraging news is that many of these health problems can be prevented—or significantly delayed—through relatively simple daily lifestyle choices. National Wellness Month therefore serves as an annual reminder that investing in healthy habits today is one of the most effective strategies for improving quality of life and extending healthy lifespan.
This year's campaign encourages everyone to prioritize five essential wellness practices:
- Drink more water.
- Eat healthy meals.
- Move your body every day.
- Reduce stress and anxiety.
- Get sufficient quality sleep.
These pillars of wellness are supported by extensive scientific evidence and remain fundamental to public health promotion worldwide.
Chronic stress has been associated with:
- Hypertension
- Depression
- Anxiety disorders
- Heart disease
- Poor immunity
- Digestive disorders
- Sleep disturbances
Stress also contributes to unhealthy coping behaviours such as:
- Smoking
- Excessive alcohol intake
- Emotional eating
- Substance abuse
Healthy stress-management techniques include:
- Deep breathing exercises
- Meditation
- Prayer
- Mindfulness
- Spending time in nature
- Listening to music
- Talking with trusted friends
- Seeking professional counselling when needed
Building resilience enables individuals to cope more effectively with life's inevitable challenges.
Prioritize Healthy Sleep
Sleep is often underestimated, yet it is one of the pillars of good health.
During sleep, the body performs numerous restorative processes including:
- Tissue repair
- Hormonal regulation
- Memory consolidation
- Immune strengthening
- Emotional processing
Adults generally require 7–9 hours of quality sleep each night.
Insufficient sleep has been linked to:
- Obesity
- Diabetes
- Heart disease
- Depression
- Poor work performance
- Reduced immunity
- Increased accident risk
Healthy sleep practices include:
- Maintaining a regular bedtime.
- Limiting screen exposure before bed.
- Avoiding heavy meals late at night.
- Reducing caffeine intake in the evening.
- Creating a quiet sleeping environment.
Sleep should be viewed as an essential investment in health rather than a luxury.

Abstract
World Breastfeeding Week (WBW), observed annually from 1–7 August, is a global campaign dedicated to protecting, promoting, and supporting breastfeeding. It serves as an opportunity to raise awareness of the indispensable role breastfeeding plays in improving maternal and child health, reducing healthcare costs, and fostering sustainable development. This article, titled "Breastfeeding for a Sustainable Start in Life: Strengthen What Works," commemorates World Breastfeeding Week 2026 by examining the scientific evidence supporting breastfeeding, its immense health, economic, social, and environmental benefits, and the need to reinforce proven interventions that improve breastfeeding practices. Drawing upon recommendations from the World Health Organization (WHO), UNICEF, peer-reviewed research, and other authoritative sources, the article emphasizes that investing in breastfeeding is one of the most effective public health strategies for building healthier families, stronger communities, and more resilient nations.
Introduction
Breastfeeding is one of humanity's oldest and most successful health interventions. Long before the development of modern medicine, it sustained human survival, protected infants from disease, and ensured healthy growth and development. Today, despite remarkable advances in healthcare technology, breastfeeding remains the biological gold standard for infant nutrition and one of the most cost-effective public health interventions available.
Every year, millions of people around the world observe World Breastfeeding Week, an international campaign coordinated by the World Alliance for Breastfeeding Action (WABA) in collaboration with the World Health Organization (WHO), UNICEF, governments, healthcare institutions, and civil society organizations. The annual observance highlights the importance of breastfeeding in improving health outcomes and mobilizes action to remove barriers that prevent mothers from breastfeeding successfully.
This commemorative article adopts the theme "Breastfeeding for a Sustainable Start in Life: Strengthen What Works" to underscore an important public health message: many effective breastfeeding interventions already exist, and greater gains will be achieved by strengthening and expanding these evidence-based strategies. Rather than replacing proven programmes, countries should invest in improving access to quality maternity care, skilled breastfeeding support, baby-friendly health facilities, workplace policies, and community education.
The Remarkable Composition of Human Milk
Breast milk is one of the most complex biological fluids known to science. More than a source of nutrition, it is a sophisticated system of protection and communication between mother and infant.
Among its many components are:
- Secretory Immunoglobulin A (IgA), which protects the respiratory and gastrointestinal mucosa.
- Lactoferrin, which inhibits bacterial growth by binding iron.
- Lysozyme, an enzyme that destroys bacterial cell walls.
- Human Milk Oligosaccharides (HMOs), which nourish beneficial gut bacteria and prevent harmful microbes from attaching to the intestinal lining.
- Living white blood cells that combat infection.
- Stem cells that continue to be studied for their potential developmental roles.
- Cytokines and chemokines that regulate immune responses.
- Hormones such as leptin, adiponectin, and ghrelin, which influence appetite and metabolism.
- Growth factors that support tissue maturation and organ development.
- Beneficial bacteria that help establish a healthy infant gut microbiome.
No commercially available infant formula can fully replicate the complexity and biological activity of these components.
Health Benefits for Infants
Breastfeeding provides extensive protection against both infectious and chronic diseases. According to the landmark Lancet Breastfeeding Series, increasing breastfeeding to near-universal levels could prevent more than 820,000 deaths among children younger than five years every year.
Breastfed infants have a significantly lower risk of:
- Diarrhoeal diseases.
- Pneumonia and other lower respiratory tract infections.
- Acute otitis media.
- Necrotizing enterocolitis, particularly among premature infants.
- Urinary tract infections.
- Sepsis in vulnerable newborns.
- Childhood obesity.
- Type 1 and Type 2 diabetes.
- Certain allergic conditions.
- Sudden Infant Death Syndrome (SIDS).
- Childhood leukaemia.
Breastfeeding also contributes to healthier oral development by promoting proper jaw growth and reducing the risk of dental malocclusion.
Furthermore, breastfed infants generally experience fewer hospital admissions, reduced antibiotic use, lower healthcare costs, and improved survival during the critical first two years of life.
Breastfeeding and Brain Development
One of the most compelling advantages of breastfeeding is its positive effect on neurological development. Human milk supplies nutrients that are essential for brain growth during the first thousand days of life—a period recognized as critical for cognitive development.
Numerous studies have reported that children who were breastfed tend to achieve higher scores on intelligence tests, perform better academically, and demonstrate improved language and problem-solving abilities. These benefits are believed to result from the combined effects of optimal nutrition, bioactive compounds in breast milk, and the close emotional interaction between mother and child during breastfeeding.
The intimate skin-to-skin contact associated with breastfeeding strengthens emotional bonding, enhances the infant's sense of security, and promotes healthy psychological development. Such early nurturing relationships form the foundation for emotional resilience and social well-being later in life.
Breastfeeding and Maternal Health
While breastfeeding is universally acknowledged as the ideal source of nutrition for infants, its health benefits for mothers are equally remarkable. Pregnancy, childbirth, and breastfeeding are interconnected physiological processes designed to protect the health of both mother and child. Scientific evidence consistently demonstrates that women who breastfeed experience both immediate and long-term health advantages.
Immediately after delivery, breastfeeding stimulates the release of oxytocin, a hormone that causes the uterus to contract. These contractions help expel the placenta, reduce postpartum bleeding, accelerate the return of the uterus to its pre-pregnancy size, and lower the risk of postpartum haemorrhage—one of the leading causes of maternal mortality globally.
Breastfeeding also increases maternal energy expenditure. Producing breast milk requires approximately 450–500 kilocalories daily, which can contribute to gradual postpartum weight loss when combined with a balanced diet and healthy lifestyle.
Long-term studies have shown that breastfeeding significantly reduces a woman's lifetime risk of several chronic diseases, including:
- Breast cancer
- Ovarian cancer
- Endometrial cancer
- Type 2 diabetes mellitus
- Hypertension
- Cardiovascular disease
- Metabolic syndrome
- Osteoporosis and hip fractures in later life
The protective effects generally increase with the total duration of breastfeeding over a woman's lifetime.
Breastfeeding also promotes psychological well-being. Frequent skin-to-skin contact and the release of oxytocin foster maternal-infant bonding, reduce stress, and may lower the risk of postpartum depression in many mothers. Nevertheless, women experiencing symptoms of depression or anxiety should receive prompt professional assessment and support while continuing breastfeeding whenever medically appropriate.
Breastfeeding During Emergencies
Breastfeeding becomes even more important during emergencies such as natural disasters, armed conflicts, disease outbreaks, and humanitarian crises.
When access to clean water, electricity, sanitation, and healthcare is disrupted, formula feeding becomes significantly more hazardous. Breastfeeding provides a safe, hygienic, readily available source of nutrition and immune protection without requiring external resources.
WHO, UNICEF, and humanitarian agencies therefore recommend protecting and supporting breastfeeding during emergencies through skilled counselling, mother-friendly spaces, and policies that prevent inappropriate donations or promotion of breast-milk substitutes.
Strengthening What Works
The title of this commemorative article—"Breastfeeding for a Sustainable Start in Life: Strengthen What Works"—captures a fundamental principle of public health: the greatest gains often come not from replacing successful programmes but from reinforcing interventions already proven to work.
Evidence consistently supports:
- Initiating breastfeeding within one hour after birth.
- Exclusive breastfeeding for the first six months.
- Continued breastfeeding with appropriate complementary feeding until at least two years of age and beyond.
- Implementation of the Baby-Friendly Hospital Initiative.
- Access to trained lactation consultants and breastfeeding counsellors.
- Enforcement of the International Code of Marketing of Breast-milk Substitutes.
- Paid maternity leave and workplace lactation support.
- Community-based mother-to-mother support groups.
- Public education based on sound scientific evidence.
- Active involvement of fathers, grandparents, employers, and community leaders in supporting breastfeeding mothers.
Strengthening these interventions will improve child survival, reduce maternal illness, lower healthcare costs, and build healthier, more sustainable societies.
The Role of Healthcare Professionals
Healthcare professionals remain the cornerstone of successful breastfeeding promotion. Every encounter with a pregnant woman or new mother presents an opportunity to educate, encourage, and support breastfeeding.
Obstetricians, family physicians, paediatricians, pharmacists, nurses, midwives, nutritionists, lactation consultants, and community health workers should work collaboratively to ensure that every mother receives accurate, evidence-based information before and after delivery.
Healthcare providers should:
- Encourage mothers to initiate breastfeeding within one hour of birth.
- Promote exclusive breastfeeding for the first six months of life.
- Support continued breastfeeding alongside safe and adequate complementary feeding until at least two years of age and beyond, as recommended by WHO.
- Teach correct positioning and attachment techniques.
- Recognise and promptly manage common breastfeeding challenges such as breast engorgement, sore nipples, mastitis, and concerns about milk supply.
- Discourage unnecessary supplementation with infant formula unless medically indicated.
- Provide compassionate, non-judgmental counselling that respects each family's circumstances.
The Role of Governments and Policymakers
Governments have a responsibility to create an enabling environment in which breastfeeding can flourish. Evidence consistently demonstrates that countries with strong breastfeeding policies achieve higher exclusive breastfeeding rates and better maternal and child health outcomes.
Priority actions include:
- Expanding the Baby-Friendly Hospital Initiative (BFHI).
- Strengthening primary healthcare services for maternal and child nutrition.
- Enforcing the International Code of Marketing of Breast-milk Substitutes and relevant World Health Assembly resolutions.
- Providing adequate paid maternity leave and workplace protections for breastfeeding mothers.
- Supporting paternity leave and family-friendly workplace policies.
- Investing in public awareness campaigns based on scientific evidence.
- Strengthening routine data collection to monitor breastfeeding practices and programme outcomes.
- Supporting research that informs national breastfeeding policies.
The Role of Employers
As more women participate in the workforce, employers play an increasingly important role in protecting breastfeeding.
Breastfeeding-friendly workplaces should provide:
- Adequate paid maternity leave.
- Flexible work arrangements where feasible.
- Designated, private, hygienic lactation rooms.
- Reasonable breastfeeding or milk-expression breaks.
- Safe facilities for temporary breast milk storage.
- Organisational cultures that respect and support breastfeeding mothers.
Such policies improve employee well-being, increase job satisfaction and retention, reduce absenteeism due to child illness, and enhance organisational productivity.
The Role of Families and Communities
Successful breastfeeding is not solely the responsibility of mothers. Fathers, grandparents, relatives, friends, faith-based organisations, traditional leaders, and community groups all have important roles to play.
Families can support breastfeeding by:
- Encouraging mothers to begin breastfeeding immediately after birth.
- Helping with household responsibilities so mothers can rest and recover.
- Providing emotional encouragement and reassurance.
- Avoiding harmful cultural practices that interfere with exclusive breastfeeding.
- Seeking professional advice promptly when breastfeeding difficulties arise.
Communities can strengthen breastfeeding by promoting positive social norms, organising mother-to-mother support groups, and protecting mothers from stigma or misinformation.
A Call to Action
Breastfeeding is not merely a personal choice; it is a public health priority and a societal responsibility. Every child deserves the healthiest possible start in life, and every mother deserves the support needed to breastfeed successfully.
Protecting, promoting, and supporting breastfeeding requires collective action from governments, healthcare professionals, employers, educators, researchers, civil society organisations, families, and communities.
The evidence is overwhelming. Breastfeeding saves lives, prevents disease, strengthens economies, reduces healthcare costs, protects the environment, and contributes to sustainable development. Few interventions deliver such broad and lasting benefits at such a modest cost.
Rather than replacing successful programmes with untested alternatives, countries should strengthen existing evidence-based interventions that have already demonstrated measurable impact. Investments in maternity protection, Baby-Friendly health facilities, skilled breastfeeding counselling, workplace support, and community education will yield benefits for generations.
Conclusion
Breastfeeding remains one of the most powerful and cost-effective public health interventions ever discovered. It is a unique biological process that nourishes infants, protects mothers, strengthens families, and contributes to healthier, more productive societies.
The message of this commemorative article—"Breastfeeding for a Sustainable Start in Life: Strengthen What Works"—is simple yet profound. Sustainable progress in maternal and child health does not always require new solutions; it often requires renewed commitment to proven strategies.

